CMC Biologics

CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time. AGC is a $12B Japanese-owned and publicly traded company based in Tokyo with over 50,000 employees in 30 countries. With three facilities in the USA and Europe, CMC Biologics provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production. CMC is experiencing growth in customer base and revenue, expanding personnel and manufacturing capacity as well as distinguishing itself in the market with unique technology offerings for clients. CMC Biologics offers a highly competitive compensation package and a friendly, collaborative culture that values personal initiative and professional achievement. EOE